Wistar scientists develop new bispecific T cell engager to target ovarian cancer
Wistar scientists have developed a new type of bispecific T cell engager, or BTE, that is effective against…
New tumor organoids strengthen precision oncology research
Significant advances have been made in the development of patient-derived tumor “organoids” for preclinical research, in two new…
Gut microbial metabolites may shape vulnerability to stress-related mental disorders
Jul 20 2026 From short-chain fatty acids to bile acids, researchers trace how microbial chemistry could influence brain…
Blood p-tau217 levels signal cognitive impairment risk years before symptoms emerge
A six-cohort analysis links higher baseline p-tau217 to rising 5- and 10-year risks, bringing presymptomatic risk models closer…
Experimental drug shows promise against NRAS-driven melanoma
A research team from Huntsman Cancer Institute at the University of Utah (the U) reports that a groundbreaking pathway-targeted therapy could be an effective…
Immune pathway may promote the progression of oral precancerous lesions
Researchers at The University of Texas MD Anderson Cancer Center identified an immune pathway that may promote the…
New drug candidate improves Parkinson’s treatment in animal models
For many people with Parkinson’s disease, the body stops moving the way it used to. A hand may…
New therapy targets Hippo pathway to fight treatment-resistant acute myeloid leukemia
Researchers at The University of Texas MD Anderson Cancer Center have discovered that an investigational epigenetic therapy remained effective in treatment-resistant acute myeloid…
Experimental compound BA-101 overcomes chemotherapy resistance in glioblastoma
Scientists have identified a promising new strategy to tackle one of the biggest obstacles in treating glioblastoma, one…
New nonhormonal therapy shows promise for treating Genitourinary Syndrome of Menopause
Researchers at the University of Colorado Anschutz have developed a promising nonhormonal therapy for women experiencing Genitourinary Syndrome…
BCG vaccine may remodel the human brain’s immune environment
New research led by Mass General Brigham investigators suggests that the Bacillus Calmette-Guérin (BCG) vaccine – which is…
Study potential new therapeutic strategy for patients with ATRX-mutant gliomas
A new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of…